BrightView AI Visibility Market Strategy Report - Addiction Treatment Centers

Answer Capsule

BrightView is effectively absent from AI-generated recommendations in the Addiction Treatment Centers category. In October 2026, BrightView recorded a 0.93% raw mention presence rate and 0.00% valid recommendation coverage across 108 qualified benchmark observations, meaning it appeared in a single answer and was never recommended for a buyer decision. The clearest win is the absence of negative framing in that one mention; the clearest weakness is that BrightView holds no recommendation credit at all while Hazelden Betty Ford holds 18.5% coverage. The clearest opportunity is to convert BrightView's existing search-visible footprint into recommendation-stage visibility, starting with the one cluster the benchmark actually measures.

Who This Report Is For

This report is for BrightView's marketing, growth, and executive leadership teams, and for anyone responsible for how the brand shows up when prospective patients and their families ask AI systems where to get addiction treatment.

Report Card

Executive Summary

BrightView is visible in the Addiction Treatment Centers category in name only. Across 108 qualified benchmark observations in October 2026, the brand recorded a 0.93% raw mention presence rate, one mention, and 0.00% valid recommendation coverage. It was never recommended, never placed in a top-three position, and never named as a first recommendation.

The single mention that did occur carried neutral framing. BrightView's net sentiment score for the month was 0.0000 because the one mention was classified as neutral, but the platform-level data shows the mention surfaced on AI Mode, where the brand carried a neutral visibility rate of 2.63%. No other tracked platform produced a BrightView mention in the qualified set.

The benchmark's only cluster with sufficient coverage is C01, Best Mental Health & Addiction Treatment Centers, a consideration-stage cluster. BrightView's entire October footprint sits inside that cluster. The two higher-intent clusters the benchmark defines, Mental Health Treatment Center Comparisons and Mental Health Treatment Center Pricing & Insurance, recorded no qualifying observations at the brand level, so the public benchmark cannot yet show how BrightView performs on comparison or pricing questions.

The gap to the category leader is structural, not marginal. Hazelden Betty Ford recorded 18.5% valid recommendation coverage, 20 valid recommendations, and 14 rank-one placements in the same 108 observations. BrightView recorded zero of each. American Addiction Centers, which also holds 0.00% recommendation coverage, still appeared in 62.0% of qualified observations, roughly 67 times more often than BrightView.

BrightView's strongest platform signal is AI Mode, where it holds a 0.9% share of the category's AI Authority Value and a 0.03% captured share of AI opportunity. Every other platform shows zero BrightView presence in the qualified set. The clearest platform gap is ChatGPT, Copilot, Gemini, Perplexity, and AI Overviews, where the brand does not appear at all.

The inconsistency data adds a second layer of risk. Three high-severity factual conflicts were detected for BrightView across four AI platforms, covering pay frequency, assisted living monthly pricing, and largest shareholder. These conflicts sit in exactly the prompt classes the qualified benchmark does not cover, which means the public benchmark understates the brand's exposure.

What BrightView Is Winning

BrightView's evidence-backed wins are narrow, and the report should say so plainly.

The brand holds one neutral mention in the qualified October set, and that mention did not carry negative framing. BrightView's negative mention count for the month was zero across every platform tracked. In a category where cautionary framing is a real risk for treatment providers, the absence of negative framing is a genuine, if small, signal.

BrightView also holds a measurable presence on AI Mode, the platform where it recorded its single mention. That platform carries the largest share of the category's modeled AI opportunity, which means the one place BrightView does appear is also the place with the most commercial weight in the benchmark.

Beyond those two points, the win column is thin. BrightView holds no top-three placements, no rank-one placements, no valid recommendations, and no presence on five of the six tracked platforms. The report should not overstate this position.

Where BrightView Has the Clearest AI Visibility Gaps

Questions This Section Answers

• Why does BrightView receive zero valid recommendations despite being mentioned in AI answers?
• Which platforms and competitors are capturing the addiction treatment recommendations BrightView is missing?
• How does BrightView's visibility compare to other treatment brands that also receive no recommendations?

BrightView's clearest gap is recommendation conversion. The brand is not merely under-recommended; it is effectively unrecommended. Across 108 qualified observations, BrightView received zero valid recommendations, zero top-three placements, and zero rank-one placements. The category leader, Hazelden Betty Ford, received 20 valid recommendations and 14 rank-one placements in the same set.

The second gap is platform coverage. BrightView appears on AI Mode and nowhere else in the qualified data. ChatGPT, Copilot, Gemini, Perplexity, and AI Overviews produced no BrightView mention that survived qualification. By contrast, Hazelden Betty Ford recorded recommendation coverage on ChatGPT (23.08%), Gemini (27.27%), Perplexity (36.36%), AI Overviews (25.00%), and AI Mode (5.26%). The leader is present and recommended across the full surface universe; BrightView is present on one surface and recommended on none.

The third gap is presence relative to peers with similar recommendation outcomes. American Addiction Centers also holds 0.00% valid recommendation coverage, but it appears in 62.0% of qualified observations. The Recovery Village holds 0.00% coverage and still appears in 22.2%. BrightView appears in 0.93%. Even among brands that are not being recommended, BrightView is the least visible.

The fourth gap is cluster coverage. BrightView's entire October footprint sits inside C01, the consideration-stage cluster. The benchmark's evaluation-stage cluster, Mental Health Treatment Center Comparisons, and its decision-stage cluster, Mental Health Treatment Center Pricing & Insurance, recorded no qualifying observations at the brand level for any tracked company. That is a benchmark limitation, not a BrightView-specific result, but it means the public data cannot yet show whether BrightView is losing comparison or pricing prompts to competitors.

Biggest Opportunity

Questions This Section Answers

• Which single cluster should BrightView prioritize to move from a mention to a recommendation?
• How does the volatility of Hazelden Betty Ford's recommendation coverage create an opening for BrightView?

BrightView's single clearest opportunity is to convert its existing search-visible and citation-visible footprint into recommendation-stage visibility inside the C01 consideration cluster, the only cluster the benchmark currently measures with sufficient coverage.

The benchmark shows that recommendation credit in this category is concentrated and volatile. Hazelden Betty Ford moved from 2.8% coverage in July 2026 to 25.2% in August, down to 7.0% in September, and back to 18.5% in October. That volatility means the recommendation slot is not permanently locked. A brand that builds a defensible answer layer for the prompts inside C01 can enter the shortlist even in a category with a dominant leader.

For BrightView specifically, the opportunity is to move from a single neutral mention to a repeatable recommendation pattern on the prompts that already surface the brand. The benchmark's C01 prompt examples include queries such as "alcohol treatment near me," "How long does a person stay in rehab?", "holistic addiction treatment," and "inpatient therapy near me." These are the prompts where a treatment provider can plausibly earn a recommendation if its owned pages, third-party profiles, and citation footprint align with what AI systems retrieve.

Competitive Landscape

Questions This Section Answers

• Which competitor dominates recommendation-stage strength in the addiction treatment category, and by how much?
• Where does BrightView rank among other treatment brands that hold zero recommendation coverage?
• What do the top-three rate, rank-one rate, and average recommended rank reveal about BrightView's position?

Hazelden Betty Ford holds recommendation-stage strength in the Addiction Treatment Centers category, with 18.5% valid recommendation coverage and a 16.7-point lead over the next closest brand. BrightView sits at the bottom of the tracked set, tied with seven other brands at 0.00% coverage but with the lowest presence rate of any brand that appeared at all.

Average recommended rank covers rank-eligible recommendations only.

BrightView's row shows zero top-three placements, zero rank-one placements, and no rank-eligible recommendations, which is why its average recommended rank is N/A. Its sentiment score of 0.0000 reflects a single neutral mention, not a negative signal. The table shows that recommendation credit in this category is concentrated in one brand and thinly distributed across two others, with the remaining eight brands, including BrightView, holding no recommendation-stage position at all.

AI Response Inconsistency Alerts

Questions This Section Answers

• What specific factual conflicts did AI platforms produce about BrightView, and on which topics?
• Which AI platforms generated the conflicting claims about BrightView's pay frequency, pricing, and ownership?
• Why do these inconsistencies matter for BrightView's AI visibility in treatment-related prompts?

Three high-severity factual inconsistencies were detected for BrightView across four AI platforms: ChatGPT, Copilot, Google AI Mode, and Perplexity. Each conflict involves a different topic, and each one is rated high severity with confidence of 0.90 or above.

The first conflict concerns BrightView's pay frequency. When asked "Does BrightView landscaping pay weekly?", Google AI Mode stated that BrightView typically pays weekly, usually on Fridays via direct deposit, citing Indeed salary pages and the BrightView corporate site. Perplexity stated that BrightView typically pays on a biweekly or semi-monthly basis rather than strictly weekly, citing ZipRecruiter salary pages for Ohio, New Jersey, and national averages. A weekly schedule and a biweekly or semi-monthly schedule are mutually exclusive standard pay frequencies for the same employer, so both answers cannot be correct.

The second conflict concerns assisted living monthly pricing. When asked "How much does Brightview cost per month?", ChatGPT stated that assisted living often starts around $4,000 to $6,000 or more per month, citing Mirador Living and Brightview Senior Living pricing pages. Perplexity stated that assisted living runs around $6,800 to $8,045 per month, citing Forbes Health, Beagle, and Assisted Living Magazine. The two ranges do not overlap, and the flagged sources on the Perplexity side include specific monthly figures such as $7,710 at Brightview Crofton Riverwalk, $6,890 at Grosvenor, and $7,200 at Brightview South River. The two answers cannot both be accurate for the same service level.

The third conflict concerns BrightView's largest shareholder or major investor. When asked "Who is the owner of BrightView landscaping?", ChatGPT stated that KKR & Co. is currently the largest shareholder with about 23.25% of BrightView's common stock as of June 30, 2026, citing Investing.com ownership data and a SEC filing. Copilot stated that the largest outside investor is One Rock Capital Partners, which made a $500 million strategic investment in 2023, citing BrightView's investor relations press release and leadership page. Both answers identify a different company as the largest outside investor, and both cannot simultaneously be the largest.

These conflicts matter because they sit in prompt classes the qualified benchmark does not cover. The benchmark's Pricing & Value and Multi-Brand Comparison clusters recorded zero qualifying observations in October 2026, which means the public benchmark cannot show how these conflicts affect recommendation behavior. The inconsistency data shows that AI systems are already producing conflicting factual claims about BrightView in the exact areas where prospective patients and partners look for clarity.

Prompt Evidence

Google AI Mode / C01 Best Mental Health & Addiction Treatment Centers Prompt: "alcohol treatment near me" Result: BrightView appeared once in the qualified set on AI Mode with neutral framing, but received no recommendation credit.

ChatGPT / C01 Best Mental Health & Addiction Treatment Centers Prompt: "How long does a person stay in rehab?" Result: BrightView did not appear in the qualified ChatGPT observations, while Hazelden Betty Ford recorded recommendation coverage of 23.08% on the same platform.

Perplexity / C01 Best Mental Health & Addiction Treatment Centers Prompt: "holistic addiction treatment" Result: BrightView did not appear in the qualified Perplexity observations, while Hazelden Betty Ford recorded recommendation coverage of 36.36% on the same platform.

Google AI Mode / C01 Best Mental Health & Addiction Treatment Centers Prompt: "inpatient therapy near me" Result: BrightView did not appear in the qualified AI Mode recommendation set, despite AI Mode being the only platform where the brand recorded any presence at all.

What CiteWorks Studio Would Do Next

Phase 1: AI Market Discovery Audit Map every prompt where BrightView appears, every prompt where it is absent, and every competitor that takes the recommendation slot in BrightView's place.

Phase 2: Recommendation Readiness Plan Prioritize the C01 consideration prompts where BrightView already has search-visible pages and third-party profiles, and define the answer-layer changes needed to move from mention to recommendation.

Phase 3: Owned Answer Layer Buildout Rebuild the BrightView pages that AI systems retrieve for treatment, location, and service questions so they answer the exact questions the benchmark prompts ask, in extractable form.

Phase 4: Citation / Authority Layer Development Strengthen the third-party profiles, directory listings, and reference sources that AI systems cite for BrightView, and correct the conflicting pay, pricing, and ownership claims surfaced in the inconsistency data.

Phase 5: Monthly AI Visibility and Recommendation Tracking Track BrightView's presence, recommendation coverage, top-three rate, and rank-one rate month over month against the same 108-observation benchmark so progress is measurable.

Why This Matters

AI systems are now part of how prospective patients and their families build a treatment shortlist. BrightView's current position in that process is close to invisible. The brand appears in fewer than one in a hundred qualified answers and is never recommended, while a single competitor holds more than ten times the recommendation coverage of the next closest brand.

Presence alone is not enough, and BrightView does not even have presence. The next move is targeted correction of the prompt, page, and citation layers that determine whether an AI system names BrightView when someone asks where to get addiction treatment. The benchmark shows where the brand stands. The work is in the answer layer that produces the recommendation.

Core Metrics

Sentiment Score

Questions This Section Answers

• Why is a neutral mention in AI answers not a positive signal for BrightView?
• What does BrightView's 0.0000 sentiment score actually measure in the context of addiction treatment recommendations?

Sentiment Score = (positive mentions × 1 + neutral mentions × 0 + negative mentions × -1) / total mentions

BrightView's October 2026 sentiment score is 0.0000. The brand recorded one mention, classified as neutral, and no positive or negative mentions. The score reflects framing quality in the single answer where BrightView appeared, not customer sentiment or brand perception.

This matters because unclassified mention counts are misleading. A brand that appears once in a neutral context and a brand that appears once in a strong recommendation are not the same signal, and a brand that appears in a cautionary or comparison-anchor context is a different signal again. Share of voice is a diagnostic metric, not a business KPI. Counting all mentions as wins is bad measurement. Classified sentiment is required before interpreting AI visibility, and for BrightView the classified picture is a single neutral mention with no recommendation credit attached.

Sentiment by Platform

Questions This Section Answers

• On which AI platform did BrightView appear at all, and how was the brand framed there?
• What does the absence of BrightView mentions on five of six tracked platforms mean for the brand's visibility?

Methodology

1. Report orientation: this is a benchmark-based AI Visibility Company Market Strategy Report for BrightView in the Addiction Treatment Centers category, built from the LLM Authority Index AI Market Discovery benchmark and the associated company-level metrics aggregation. It is not a client implementation result.
2. Reporting window: October 2026, with July 2026 as the baseline month and August 2026 and September 2026 as intermediate measurement months.
3. Platforms tracked: six canonical AI surface families, ChatGPT, Copilot, Gemini, Perplexity, AI Overviews, and AI Mode.
4. Observation count: 108 qualified benchmark observations in October 2026, drawn from 662 raw prompt-surface observations and 505 unique questions.
5. Competitor universe: 11 tracked brands, Acadia Healthcare, American Addiction Centers, Banyan Treatment Centers, BrightView, Caron Treatment Centers, Gateway Foundation, Hazelden Betty Ford, Jobscai, Phoenix House, Recovery Centers of America, and The Recovery Village.
6. Public clusters used: three buyer-intent clusters are defined, C01 Best Mental Health & Addiction Treatment Centers, C02 Mental Health Treatment Center Comparisons, and C03 Mental Health Treatment Center Pricing & Insurance. Only C01 recorded sufficient coverage in October 2026.
7. Stage 0 role: the raw collection stage captures prompt-surface observations across the AI surface universe. Qualification removes irrelevant observations and produces the public denominator used for all brand-level rates.
8. Definition of a mention: a mention is any qualified observation where the brand appears in the AI response in any capacity, including neutral, contextual, or comparison-anchor references.
9. Definition of a valid recommendation: a valid recommendation is a qualified observation where the brand receives a recommendation usable for a buyer decision. Neutral, cautionary, comparison-anchor, and listed-only mentions are not counted as valid recommendations.
10. Ranking interpretation: top-three rate is the share of qualified observations where the brand appears in one of the first three recommended positions. Rank-one rate is the share where the brand is the single first recommendation. Average recommended rank covers rank-eligible recommendations only.
11. Data limitation: the public benchmark does not measure market share, sales, organic-search ranking, social mention volume, or attributable sales, and no metric movement in the benchmark establishes causality. Brand-level rates reflect the qualified public denominator and should not be read as revenue or demand outcomes.
12. Taxonomy note: the benchmark's C02 and C03 clusters recorded zero qualifying observations in October 2026, so this report cannot present comparison or pricing recommendation outcomes for BrightView or any tracked brand.

See How AI Is Recommending Your Brand

The public benchmark shows where BrightView stands in AI-generated recommendations across the Addiction Treatment Centers category. A company-level AI visibility audit maps the specific prompts, competitors, platforms, and citation sources behind that position, and turns the benchmark readout into a prioritized plan for moving from mention to recommendation.